Rebecca Raelynn Mcclung, PHARM D is a
Pharmacist based in New Haven, West Virginia. Rebecca Raelynn Mcclung is licensed to practice in West Virginia (license number 0009413) and her current practice location is
307 5th St, New Haven, West Virginia. She can be reached at her office (for appointments etc.) via phone at
(304) 882-2005.
NPI number for Rebecca Raelynn Mcclung is 1689020109 and her current mailing address is Po Box 186, New Haven, West Virginia. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1689020109.
Healthcare Provider's Profile
Full Name | Rebecca Raelynn Mcclung |
---|
Gender | Female |
---|
Speciality | Pharmacist |
---|
Location | 307 5th St, New Haven, West Virginia |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1689020109
- Provider Enumeration Date: 05/13/2016
- Last Update Date: 11/11/2021
Medical Identifiers
Medical identifiers for Rebecca Raelynn Mcclung such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1689020109 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
183500000X | Pharmacist | 03135299 (Ohio) | Secondary |
183500000X | Pharmacist | 0009413 (West Virginia) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Rebecca Raelynn Mcclung is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Rebecca Raelynn Mcclung, PHARM D Po Box 186, New Haven, WV 25265-0186 Ph: (304) 882-2005 | Rebecca Raelynn Mcclung, PHARM D 307 5th St, New Haven, WV 25265-4100 Ph: (304) 882-2005 |
Reviews and Comments